Management of the australianclinicaltrials.gov.au website has been transferred from NHMRC to the Commonwealth Department of Health. Disruption to site users as a consequence of this change should be minimal.
Broad Health Condition Inflammatory and Immune System
Specific Health ConditionRheumatoid arthritis
Anticipated date of first participant enrolment1/07/2004
Anticipated date of last participant enrolment1/07/2004
The primary purpose is to determine whether growth hormone and androgens alter protein metabolism in a way that will reduce protein loss in long-term glucocorticoid users. If so they may be a potential therapy to reduce the skin thinning and muscle weakness that occurs during longterm glucocorticoid use.
Sponsor Primary Sponsor Type: Hospital
Primary Sponsor Name: St Vincent's Hospital
Primary Sponsor Country: Australia
Contact person for information and recruitment
Professor Ken Ho
Pituitary Research Unit Garvan Institute of Medical Research 384 Victoria St Darlinghurst NSW 2010
+61 2 92958482
+61 2 92958481